Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

124 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bioengineered vascular grafts: can we make them off-the-shelf?
Dahl SL, Blum JL, Niklason LE. Dahl SL, et al. Among authors: blum jl. Trends Cardiovasc Med. 2011 Apr;21(3):83-9. doi: 10.1016/j.tcm.2012.03.004. Trends Cardiovasc Med. 2011. PMID: 22626247 Review.
Readily available tissue-engineered vascular grafts.
Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE. Dahl SL, et al. Among authors: blum jl. Sci Transl Med. 2011 Feb 2;3(68):68ra9. doi: 10.1126/scitranslmed.3001426. Sci Transl Med. 2011. PMID: 21289273
Relevance and safety of telomerase for human tissue engineering.
Klinger RY, Blum JL, Hearn B, Lebow B, Niklason LE. Klinger RY, et al. Among authors: blum jl. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2500-5. doi: 10.1073/pnas.0508184103. Epub 2006 Feb 13. Proc Natl Acad Sci U S A. 2006. PMID: 16477025 Free PMC article.
Prenatal Exposure to Gutkha, a Globally Relevant Smokeless Tobacco Product, Induces Hepatic Changes in Adult Mice.
Doherty Lyons S, Blum JL, Hoffman-Budde C, Tijerina PB, Fiel MI, J Conklin D, Gany F, Odin JA, Zelikoff JT. Doherty Lyons S, et al. Among authors: blum jl. Int J Environ Res Public Health. 2020 Oct 28;17(21):7895. doi: 10.3390/ijerph17217895. Int J Environ Res Public Health. 2020. PMID: 33126512 Free PMC article.
Prenatal Exposure to Electronic-Cigarette Aerosols Leads to Sex-Dependent Pulmonary Extracellular-Matrix Remodeling and Myogenesis in Offspring Mice.
Wang Q, Sundar IK, Blum JL, Ratner JR, Lucas JH, Chuang TD, Wang Y, Liu J, Rehan VK, Zelikoff JT, Rahman I. Wang Q, et al. Among authors: blum jl. Am J Respir Cell Mol Biol. 2020 Dec;63(6):794-805. doi: 10.1165/rcmb.2020-0036OC. Am J Respir Cell Mol Biol. 2020. PMID: 32853043
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.
Litton JK, Hurvitz SA, Mina LA, Rugo HS, Lee KH, Gonçalves A, Diab S, Woodward N, Goodwin A, Yerushalmi R, Roché H, Im YH, Eiermann W, Quek RGW, Usari T, Lanzalone S, Czibere A, Blum JL, Martin M, Ettl J. Litton JK, et al. Among authors: blum jl. Ann Oncol. 2020 Nov;31(11):1526-1535. doi: 10.1016/j.annonc.2020.08.2098. Epub 2020 Aug 20. Ann Oncol. 2020. PMID: 32828825
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancer.
Tripathy D, Blum JL, Rocque GB, Bardia A, Karuturi MS, Cappelleri JC, Liu Y, Zhang Z, Davis KL, Wang Y. Tripathy D, et al. Among authors: blum jl. Future Oncol. 2020 Nov;16(31):2475-2485. doi: 10.2217/fon-2020-0573. Epub 2020 Aug 13. Future Oncol. 2020. PMID: 32787449 Free article.
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, Fehrenbacher L, Mina LA, Diab S, Woodward NE, Yerushalmi R, Goodwin A, Blum JL, Martin M, Quek RGW, Tudor IC, Bhattacharyya H, Gauthier E, Litton JK, Eiermann W. Rugo HS, et al. Among authors: blum jl. JNCI Cancer Spectr. 2019 Oct 21;4(1):pkz085. doi: 10.1093/jncics/pkz085. eCollection 2020 Feb. JNCI Cancer Spectr. 2019. PMID: 32337496 Free PMC article.
Neuroinflammatory and Behavioral Outcomes Measured in Adult Offspring of Mice Exposed Prenatally to E-Cigarette Aerosols.
Church JS, Chace-Donahue F, Blum JL, Ratner JR, Zelikoff JT, Schwartzer JJ. Church JS, et al. Among authors: blum jl. Environ Health Perspect. 2020 Apr;128(4):47006. doi: 10.1289/EHP6067. Epub 2020 Apr 15. Environ Health Perspect. 2020. PMID: 32293200 Free PMC article.
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
Hurvitz SA, Gonçalves A, Rugo HS, Lee KH, Fehrenbacher L, Mina LA, Diab S, Blum JL, Chakrabarti J, Elmeliegy M, DeAnnuntis L, Gauthier E, Czibere A, Tudor IC, Quek RGW, Litton JK, Ettl J. Hurvitz SA, et al. Among authors: blum jl. Oncologist. 2020 Mar;25(3):e439-e450. doi: 10.1634/theoncologist.2019-0493. Epub 2019 Nov 25. Oncologist. 2020. PMID: 32162822 Free PMC article.
124 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback